Northern Trust Corp Synlogic, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$1.63 - $2.55 $27,227 - $42,595	16,704 Added 21.65%	93,863 $225,000
Q4 2021 Feb 08, 2022	BUY	$2.27 - $3.0 $23,208 - $30,672	10,224 Added 15.27%	77,159 $187,000
Q3 2021 Nov 15, 2021	SELL	$2.45 - $4.1 $4,728 - $7,912	-1,930 Reduced 2.8%	66,935 $204,000
Q2 2021 Aug 13, 2021	BUY	$3.0 - $4.39 $92,598 - $135,501	30,866 Added 81.23%	68,865 $268,000
Q1 2021 May 12, 2021	BUY	$2.2 - $5.05 $2,043 - $4,691	929 Added 2.51%	37,999 $136,000
Q4 2020 Feb 11, 2021	SELL	$1.85 - $2.54 $22 - $30	-12 Reduced 0.03%	37,070 $80,000
Q3 2020 Nov 16, 2020	SELL	$1.85 - $2.57 $1,816 - $2,523	-982 Reduced 2.58%	37,082 $75,000
Q2 2020 Aug 14, 2020	SELL	$1.59 - $2.51 $226,010 - $356,783	-142,145 Reduced 78.88%	38,064 $77,000
Q1 2020 May 14, 2020	BUY	$1.39 - $3.19 $8,971 - $20,588	6,454 Added 3.71%	180,209 $310,000
Q4 2019 Feb 14, 2020	SELL	$1.96 - $2.81 $24,445 - $35,046	-12,472 Reduced 6.7%	173,755 $448,000
Q3 2019 Nov 13, 2019	SELL	$2.12 - $9.37 $32,618 - $144,166	-15,386 Reduced 7.63%	186,227 $427,000
Q2 2019 Aug 13, 2019	BUY	$6.27 - $9.48 $184,344 - $278,721	29,401 Added 17.07%	201,613 $1.84 Million
Q1 2019 May 13, 2019	BUY	$7.01 - $10.24 $35,589 - $51,988	5,077 Added 3.04%	172,212 $1.31 Million
Q4 2018 Feb 12, 2019	BUY	$5.95 - $14.49 $11,929 - $29,052	2,005 Added 1.21%	167,135 $1.17 Million
Q3 2018 Nov 14, 2018	BUY	$7.51 - $14.21 $94,918 - $179,600	12,639 Added 8.29%	165,130 $2.35 Million
Q2 2018 Aug 14, 2018	BUY	$9.01 - $13.33 $1.13 Million - $1.68 Million	125,916 Added 473.81%	152,491 $1.5 Million
Q1 2018 May 09, 2018	BUY	$9.38 - $12.12 $249,273 - $322,089	26,575 New	26,575 $249,000

Others Institutions Holding SYBX

# of Institutions

Shares Held

25.5K

Call Options Held

Put Options Held

View Full List

About SYNLOGIC, INC.

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $105M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

More about SYBX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account